Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis

Head and Neck

Volumn 33, Issue 2, 2011, Pages 267-273

  Fischer, Claude A ^a   Jung, Minoa ^a   Zlobec, Inti ^b   Green, Edith ^a   Storck, Claudio ^a   Tornillo, Luigi ^b   Lugli, Alessandro ^b   Wolfensberger, Markus ^a   Terracciano, Luigi M ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

head and neck squamous cell carcinoma; Ki 67; p21; radio resistance; senescence

Indexed keywords

KI 67 ANTIGEN; PLATINUM DERIVATIVE; PROTEIN P21;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LARYNX CARCINOMA; MALE; OVERALL SURVIVAL; PHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TREATMENT OUTCOME;

BIOPSY; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN KINASE INHIBITORS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 78751498295     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21440     Document Type: Article

References (39)

1. Pignon JP, Bourhis J, Domenge C, Designe L,. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Meta-Analysis of Chemotherapy on Head and Neck Cancer Collaborative Group. Lancet 2000; 355: 949-955.
2. Chang BD, Watanabe K, Broude EV, et al. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci U S A 2000; 97: 4291-4296.
3. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J,. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A 2001; 98: 12072-12077.
4. el Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
5. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC,. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A 1996; 93: 13742-13747.
6. Dotto GP,. p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 2000; 1471: M43-M56.
7. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X,. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999; 15: 269-290.
8. Martin-Caballero J, Flores JM, Garcia-Palencia P, Serrano M,. Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res 2001; 61: 6234-6238.
9. Chang BD, Swift ME, Shen M, Fang J, Broude EV, Roninson IB,. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci U S A 2002; 99: 389-394.
10. Gerdes J, Schwab U, Lemke H, Stein H,. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13-20.
11. Ritta M, De Andrea M, Mondini M, et al. Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Head Neck 2009; 31: 318-327.
12. Faratzis G, Tsiambas E, Rapidis AD, et al. VEGF and Ki 67 expression in squamous cell carcinoma of the tongue: an immunohistochemical and computerized image analysis study. Oral Oncol 2009; 45: 584-588.
13. Wangsa D, Ryott M, Avall-Lundqvist E, et al. Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma. Br J Cancer 2008; 99: 1121-1128.
14. Grabenbauer GG, Muhlfriedel C, Rodel F, et al. Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2000; 48: 1041-1050.
15. Lavertu P, Adelstein DJ, Myles J, Secic M,. p53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy. Laryngoscope 2001; 111: 1878-1892.
16. Couture C, Raybaud-Diogene H, Tetu B, et al. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma. Cancer 2002; 94: 713-722.
17. Buffa FM, Bentzen SM, Daley FM, et al. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy. Clin Cancer Res 2004; 10: 3745-3754.
18. Wilson GD, Saunders MI, Dische S, et al. Pre-treatment proliferation and the outcome of conventional and accelerated radiotherapy. Eur J Cancer 2006; 42: 363-371.
19. Sauter G, Simon R, Hillan K,. Tissue microarrays in drug discovery. Nat Rev Drug Discov 2003; 2: 962-972.
20. Zlobec I, Steele R, Terracciano L, Jass JR, Lugli A,. Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol 2007; 60: 1112-1116.
21. Fischer C, Zlobec I, Stockli E, et al. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas. Hum Pathol 2008; 39: 1527-1534.
22. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ,. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
23. Ng IO, Lam KY, Ng M, Regezi JA,. Expression of p21/waf1 in oral squamous cell carcinomas-correlation with p53 and mdm2 and cellular proliferation index. Oral Oncol 1999; 35: 63-69.
24. Korkmaz H, Du W, Yoo GH, et al. Prognostic significance of G1 cell-cycle inhibitors in early laryngeal cancer. Am J Otolaryngol 2005; 26: 77-82.
25. Pruneri G, Pignataro L, Carboni N, et al. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer. J Clin Oncol 1999; 17: 3150-3159.
26. Hirvikoski P, Kellokoski JK, Kumpulainen EJ, Virtaniemi JA, Johansson RT, Kosma VM,. Downregulation of p21/WAF1 is related to advanced and dedifferentiated laryngeal squamous cell carcinoma. J Clin Pathol 1999; 52: 440-444.
27. Jeannon JP, Soames J, Lunec J, Awwad S, Ashton V, Wilson JA,. Expression of cyclin-dependent kinase inhibitor p21(WAF1) and p53 tumour suppressor gene in laryngeal cancer. Clin Otolaryngol Allied Sci 2000; 25: 23-27.
28. Chien CY, Huang CC, Cheng JT, Chen CM, Hwang CF, Su CY,. The clinicopathological significance of p53 and p21 expression in squamous cell carcinoma of hypopharyngeal cancer. Cancer Lett 2003; 201: 217-223.
29. van Oijen MG, Tilanus MG, Medema RH, Slootweg PJ,. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med 1998; 27: 367-375.
30. Gonzalez-Moles MA, Gil-Montoya JA, Ruiz-Avila I, Esteban F, Delgado-Rodriguez M, Bascones-Martinez A,. Prognostic significance of p21WAF1/CIP1, p16INK4a and CD44s in tongue cancer. Oncol Rep 2007; 18: 389-396.
31. Yook JI, Kim J,. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Oral Oncol 1998; 34: 198-203.
32. Erber R, Klein W, Andl T, et al. Aberrant p21(CIP1/WAF1) protein accumulation in head-and-neck cancer. Int J Cancer 1997; 74: 383-389.
33. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR,. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211: 90-98.
34. Zhang Y, Fujita N, Tsuruo T,. Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene 1999; 18: 1131-1138.
35. Wang YA, Elson A, Leder P,. Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc Natl Acad Sci U S A 1997; 94: 14590-14595.
36. van Diest PJ, Brugal G, Baak JP,. Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol 1998; 51: 716-724.
37. Pich A, Chiusa L, Navone R,. Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol 2004; 15: 1319-1329.
38. Piffko J, Bankfalvi A, Ofner D, et al. Standardized AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas. J Pathol 1997; 182: 450-456. (Pubitemid 27317211)
39. Fizazi K, Martinez LA, Sikes CR, et al. The association of p21(WAF-1/CIP1) with progression to androgen-independent prostate cancer. Clin Cancer Res 2002; 8: 775-781.